Cargando…
Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate
[Image: see text] The clinical impact and accessibility of (99m)Tc tracers for cancer diagnosis would be greatly enhanced by the availability of a new, simple, and easy labeling process and radiopharmaceuticals. In this study, Technetium-99m-imatinib mesylate ([(99m)Tc]TcIMT) was developed and prepa...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2020
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081423/ https://www.ncbi.nlm.nih.gov/pubmed/32201818 http://dx.doi.org/10.1021/acsomega.9b04327 |